Villalon, Virginia B.
HRN: 24-31-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CEFTAZIDIME 1GM (VIAL)
01/04/2024
01/10/2024
IV
1g
Q8
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes